COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia

Shyh Poh Teo

doi:10.11909/j.issn.1671-5411.2021.11.006

Please cite this article as: Teo SP. COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia. J Geriatr Cardiol 2021; 18(11): 952−956. DOI: 10.11909/j.issn.1671-5411.2021.11.006.

Citation:

Please cite this article as: Teo SP. COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia. J Geriatr Cardiol 2021; 18(11): 952−956. DOI: 10.11909/j.issn.1671-5411.2021.11.006.

Citation:

Please cite this article as: Teo SP. COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia. J Geriatr Cardiol 2021; 18(11): 952−956. DOI: 10.11909/j.issn.1671-5411.2021.11.006.

COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia

Shyh Poh Teo

Graphical Abstract

Abstract

FullText(HTML)

References (35)

COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia

Catalog

Export File

Citation

Format

Content